291 related articles for article (PubMed ID: 15364688)
1. Botulinum toxin type A for treating voice tremor.
Adler CH; Bansberg SF; Hentz JG; Ramig LO; Buder EH; Witt K; Edwards BW; Krein-Jones K; Caviness JN
Arch Neurol; 2004 Sep; 61(9):1416-20. PubMed ID: 15364688
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of botulinum toxin type B (Myobloc) in adductor spasmodic dysphonia.
Adler CH; Bansberg SF; Krein-Jones K; Hentz JG
Mov Disord; 2004 Sep; 19(9):1075-9. PubMed ID: 15372600
[TBL] [Abstract][Full Text] [Related]
3. A new paradigm for the management of essential vocal tremor with botulinum toxin.
Gurey LE; Sinclair CF; Blitzer A
Laryngoscope; 2013 Oct; 123(10):2497-501. PubMed ID: 23553653
[TBL] [Abstract][Full Text] [Related]
4. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.
Kendall KA; Leonard RJ
J Voice; 2011 Jan; 25(1):114-9. PubMed ID: 20137891
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of the vocal tremor scoring system.
Bové M; Daamen N; Rosen C; Wang CC; Sulica L; Gartner-Schmidt J
Laryngoscope; 2006 Sep; 116(9):1662-7. PubMed ID: 16955000
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of essential voice tremor: a study of 34 cases.
Sulica L; Louis ED
Laryngoscope; 2010 Mar; 120(3):516-28. PubMed ID: 20066728
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
[TBL] [Abstract][Full Text] [Related]
8. The treatment of essential voice tremor with botulinum toxin A: a longitudinal case report.
Warrick P; Dromey C; Irish J; Durkin L
J Voice; 2000 Sep; 14(3):410-21. PubMed ID: 11021508
[TBL] [Abstract][Full Text] [Related]
9. Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia.
Adams SG; Hunt EJ; Irish JC; Charles DA; Lang AE; Durkin LC; Wong DL
J Otolaryngol; 1995 Dec; 24(6):345-51. PubMed ID: 8699600
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal effects of Botox injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia: part II.
Rubin AD; Wodchis WP; Spak C; Kileny PR; Hogikyan ND
Arch Otolaryngol Head Neck Surg; 2004 Apr; 130(4):415-20. PubMed ID: 15096423
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.
Blitzer A; Brin MF; Stewart CF
Laryngoscope; 1998 Oct; 108(10):1435-41. PubMed ID: 9778279
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin injection and airflow stability in spasmodic dysphonia.
Cantarella G; Berlusconi A; Maraschi B; Ghio A; Barbieri S
Otolaryngol Head Neck Surg; 2006 Mar; 134(3):419-23. PubMed ID: 16500438
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.
Hogikyan ND; Wodchis WP; Spak C; Kileny PR
J Voice; 2001 Dec; 15(4):576-86. PubMed ID: 11792036
[TBL] [Abstract][Full Text] [Related]
14. A prospective crossover trial of botulinum toxin chemodenervation versus injection augmentation for essential voice tremor.
Estes C; Sadoughi B; Coleman R; Sarva H; Mauer E; Sulica L
Laryngoscope; 2018 Feb; 128(2):437-446. PubMed ID: 28988441
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of propranolol and botulinum for the treatment of essential voice tremor.
Justicz N; Hapner ER; Josephs JS; Boone BC; Jinnah HA; Johns MM
Laryngoscope; 2016 Jan; 126(1):113-7. PubMed ID: 26198384
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin A and B: a comparative dosing study for spasmodic dysphonia.
Blitzer A
Otolaryngol Head Neck Surg; 2005 Dec; 133(6):836-8. PubMed ID: 16360499
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin treatment of false vocal folds in adductor spasmodic dysphonia: Functional outcomes.
Simpson CB; Lee CT; Hatcher JL; Michalek J
Laryngoscope; 2016 Jan; 126(1):118-21. PubMed ID: 26467807
[TBL] [Abstract][Full Text] [Related]
18. Perceptual analyses of spasmodic dysphonia before and after treatment.
Cannito MP; Woodson GE; Murry T; Bender B
Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1393-9. PubMed ID: 15611398
[TBL] [Abstract][Full Text] [Related]
19. Laryngeal Botulinum Toxin Injection for Vocal Tremor: Utility of Concurrent Strap Muscle Injection.
Nelson RC; Silva Merea V; Tierney WS; Milstein C; Benninger MS; Bryson PC
Laryngoscope; 2019 Jun; 129(6):1433-1437. PubMed ID: 30588631
[TBL] [Abstract][Full Text] [Related]
20. Combined modality treatment of adductor spasmodic dysphonia.
Silverman EP; Garvan C; Shrivastav R; Sapienza CM
J Voice; 2012 Jan; 26(1):77-86. PubMed ID: 21292439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
